GlassScriptPhysician profile
Danielle K Arthur
NPI 1003477118
$1,381.71
in general payments reported to CMS, 2019-2025
11 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.35 · 2022: $264 · 2023: $438 · 2024: $553 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.64 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.76 | 2021-2025 | |
| Lilly USA, LLC | $298.56 | 2022-2025 | Mounjaro, Zepbound |
| Alexion Pharmaceuticals, INC. | $177.33 | 2022-2024 | Strensiq |
| Glaxosmithkline, LLC. | $105.27 | 2022-2024 | Bexsero, Shingrix |
| Axsome Therapeutics, INC. | $94.96 | 2024 | Auvelity |
| Ultragenyx Pharmaceutical INC. | $79.61 | 2022 | |
| Exact Sciences Corporation | $74.56 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $66.49 | 2023-2024 | Veozah, Myrbetriq |
| Novo Nordisk INC | $49.81 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Biohaven Pharmaceutical Holding Company LTD. | $16.40 | 2022 | |
| Heartflow, INC. | $14.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.